Latest news – Page 284
-
NewsMolnupiravir dose of human effect size-equivalent blocks Covid transmission in ferrets
Two oral drugs provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models, but only molnupiravir efficiently blocked SARS-CoV-2 transmission when administered at a human effect size-equivalent dose.
-
NewsHigh-tech microscope using AI detects malaria in returning travellers
Researchers have tested the accuracy of an automated microscope combined with AI software to identify malaria parasites in blood samples – an additional diagnostic approach to disease detection.
-
NewsSynthetic antibiotic could be effective against drug-resistant superbugs
Researchers have found a new antibiotic strategy to defeat gram-negative bacteria like Salmonella, Pseudomonas and E. coli, making use of a synthetic molecule that works fast and is durable in animal tests.
-
NewsEngineered probiotic developed to treat multiple sclerosis
Researchers are working on a new approach to target autoimmunity in the brain, leveraging designer bacteria to make treatment safer and more effective.
-
-
NewsInflammation slows malaria parasite growth and reproduction in the body
Researchers have found that inflammation in the body can slow down the development of malaria parasites in the bloodstream.
-
NewsCo-infection by novel species of parasite found in visceral leishmaniasis patient
Genome sequencing of clinical samples from a child has revealed the simultaneous presence of the protozoan Leishmania infantum and an as-yet unnamed parasite that was identified earlier in a fatal case of visceral leishmaniasis.
-
NewsBooster shot being developed to fight koala Chlamydia
Researchers are developing a booster vaccine using implant technology in the fight against the deadly Chlamydia disease that has decimated koala colonies.
-
NewsModulating type 1 Interferon may expand treatment options for COVID-19
Researchers have, for the first time in nonhuman primates, studied how modulating the signaling of type 1 Interferon (IFN-I), one of the body’s initial defenses against infection, impacts SARS-CoV-2 viral replication and disease progression.
-
NewsScientists discover broadly neutralizing antibodies that contribute to HIV control
Researchers have investigated and revealed how neutralizing antibodies, including those described as broadly neutralizing, contribute to HIV control.
-
NewsResearchers find chink in the armour of tuberculosis pathogen
Discovery of drug resistance network could clear way for developing a drug to prevent pathogen from resisting and tolerating tuberculosis treatment.
-
NewsSustainable Microbiology issues call for papers focusing on the human microbiome
The peer-reviewed scientific journal Sustainable Microbiology has announced that it will be issuing a Themed Collection focusing on the human microbiome.
-
NewsAMR poses threat in all 35 countries in the Americas
569,000 deaths were linked to bacterial antimicrobial resistance in all 35 countries of the WHO Region of the Americas, according to a new study.
-
NewsResearchers reveal how the herpes virus HCMV deceives its host cells
Researchers have created a detailed map of the spatial interactions between viral and host cell proteins within HCMV particles, revealing that certain host cell proteins are recruited by viral proteins and play a role in viral replication.
-
NewsEgyptian cotton gene grants powerful resistance to resurging blight
An overlooked gene found in Egyptian cotton confers powerful resistance to bacterial blight, a plant disease that is threatening cotton production worldwide.
-
NewsCyanobacteria can ‘grow’ stronger sand-based construction materials
Researchers have successfully grown bacterial cells in potential sand-based construction materials, according to a study charting the novel development of an additive co-fabrication manufacturing process.
-
NewsFlu deaths rise when pro sports teams move into cities
West Virginia University economists, whose research shows flu deaths increase when a city becomes home to a new professional sports team, say their data should make even the biggest fans reconsider support for taxpayer-funded stadium subsidies.
-
NewsAspergillus fumigatus adapts to life in humans - and shapes their lung microbiome
Aspergillus fumigatus strains that infect humans have a significantly altered metabolism compared to other strains in the environment. At the same time, infection with the fungus leads to an apparent change in the human lung microbiome. Source: CDC Photomicrograph revealing ultrastructural morphology exhibited by the fungal organism Aspergillus ...
-
NewsCurrent estimates of Lake Erie algae toxicity may miss the mark
A new study of the annual harmful algal bloom (HAB) in Lake Erie suggests that the toxicity of the bloom may be overestimated in earlier warm months and underestimated later in the summer.
-
NewsMonoclonal antibody shows promise for treating chronic hepatitis B and D infections
In a preclinical study, the potential of an engineered investigational human monoclonal antibody for the treatment of chronic hepatitis B and hepatitis D has been demonstrated.